NSTEMI - NON-ST SEGMENT ELEVATION MI
Clinical trials for NSTEMI - NON-ST SEGMENT ELEVATION MI explained in plain language.
Never miss a new study
Get alerted when new NSTEMI - NON-ST SEGMENT ELEVATION MI trials appear
Sign up with your email to follow new studies for NSTEMI - NON-ST SEGMENT ELEVATION MI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart attack treatment aims to slash cholesterol, prevent repeat events
Disease control OngoingThis study is testing if adding a cholesterol-lowering injection called evolocumab to standard care is better at reaching very low cholesterol goals after a heart attack. It involves over 2,100 patients in Europe who have had a serious heart attack and received a stent. The main …
Matched conditions: NSTEMI - NON-ST SEGMENT ELEVATION MI
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Race against time: study tests 1-Hour vs. 3-Hour heart attack test
Diagnosis OngoingThis large study aims to see if a faster blood test can safely and accurately diagnose heart attacks. It compares a new 1-hour testing method against the current standard 3-hour method in emergency room patients with chest pain. The goal is to see if the faster test works just as…
Matched conditions: NSTEMI - NON-ST SEGMENT ELEVATION MI
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Mar 12, 2026 13:52 UTC